Related references
Note: Only part of the references are listed.Darbepoetin alfa for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled study
Robert E. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Erythropoietin and its lost receptor
Alessio Sturiale et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Erythropoietin receptors on cancer cells: A still open question
Fulvio Della Ragione et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Problems in identifying functional erythropoietin receptors in cancer tissue
Wolfgang Jelkmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia
James R. Wright et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Erythropoietin receptor expression in non-small cell lung carcinoma: A question of antibody specificity
W. Mark Brown et al.
STEM CELLS (2007)
Effect of treatment with epoetin beta on short-term tumour progression and survival in anaemic patients with cancer:: a meta-analysis
M. Aapro et al.
BRITISH JOURNAL OF CANCER (2006)
Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial
PM Wilkinson et al.
BRITISH JOURNAL OF CANCER (2006)
Darbepoetin alfa administered every three weeks is effective for the treatment of chemotherapy-induced anemia
Ralph Boccia et al.
ONCOLOGIST (2006)
Cancer-related anemia and recombinant human erythropoietin - an updated overview
J Bohlius et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Anti-Epo receptor antibodies do not predict Epo receptor expression
S Elliott et al.
BLOOD (2006)
Randomized, double-blind, active-controlled trial of every-3-week darbepoetin alfa for the treatment of chemotherapy-induced anemia
JL Canon et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Efficacy and safety analysis of epoetin alfa in patients with small-cell lung cancer: A randomized, double-blind, placebo-controlled trial
T Grote et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: A survival study
B Leyland-Jones et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy:: randomised, double-blind, placebo-controlled trial
M Henke et al.
LANCET (2003)
Erythropoietin regulates tumour growth of human malignancies
Y Yasuda et al.
CARCINOGENESIS (2003)
Share Paper
